Fri, Sep 19, 2014, 8:03 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • arthurs1 arthurs1 May 29, 2013 5:01 PM Flag

    ISIS drug will prove to be better, has fewer limitations, drug interactions etc etc

    2013 NATIONAL LIPID ASSOCIATION ANNUAL SCIENTIFIC SESSIONS
    MAY 30-JUNE 2, 2013
    LAS VEGAS, NV
    Session Type Poster Presentation
    Session Title Pharmacological Control of Lipids and Lipoproteins
    Dates and Times Friday, May 31, 2013 – 1:00 p.m. to 2:00 p.m. PT
    Saturday, June 1, 2013 – 12:30 p.m. to 1:30 p.m. PT
    Poster Number 167
    Presentation Title
    LONG TERM EFFICACY AND SAFETY OF MIPOMERSEN
    DURING 4 YEARS OF TREATMENT IN A COHORT OF
    PATIENTS WITH HETEROZYGOUS FAMILIAL
    HYPERCHOLESTEROLEMIA AND CORONARY ARTERY
    DISEASE (CAD)
    Duell PB1, Rose JE1, Selvey S2, Alam S2, Mittleman RS2
    1Oregon Health & Science University, Portland, OR 2Genzyme, a Sanofi
    Company, Cambridge, MA
    Session Type Poster Presentation
    Session Title Pharmacological Control of Lipids and Lipoproteins
    Dates and Times Friday, May 31, 2013 – 1:00 p.m. to 2:00 p.m. PT
    Saturday, June 1, 2013 – 12:30 p.m. to 1:30 p.m. PT
    Poster Number 168
    Presentation Title
    LACK OF DRUG-DRUG INTERACTION BETWEEN
    MIPOMERSEN AND WARFARIN IN HEALTHY VOLUNTEER

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEGR
32.87-1.23(-3.61%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.